logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Ergotamine Derivative class drugs

    FiltersReset Filters
    4 results

    • dihydroergotamine mesylate

      (Dihydroergotamine Mesylate)
      Hikma Pharmaceuticals USA Inc.
      Usage: Dihydroergotamine mesylate nasal spray is indicated for the acute treatment of migraine headaches, with or without aura. It is not for prophylactic therapy or the management of hemiplegic or basilar migraine.

    • dihydroergotamine mesylate

      (Dihydroergotamine mesylate)
      Advagen Pharma Ltd
      Usage: Dihydroergotamine mesylate nasal spray is indicated for the acute treatment of migraine headaches, with or without aura. It is not intended for migraine prevention or the management of hemiplegic or basilar migraines.

    • dihydroergotamine mesylate nasal

      (Dihydroergotamine Mesylate Nasal)
      Cipla USA Inc.
      Usage: Dihydroergotamine mesylate nasal spray is indicated for the acute treatment of migraine headaches, with or without aura. It is not intended for migraine prophylaxis or for managing hemiplegic or basilar migraines.

    • trudhesa

      (Dihydroergotamine mesylate)
      Impel Pharmaceuticals Inc.
      Usage: TRUDHESA is indicated for the acute treatment of migraine with or without aura in adults. It is not intended for preventive treatment or for managing hemiplegic or basilar migraines.